Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
Nature. 2023 Sep;621(7980):701-710. doi: 10.1038/s41586-023-06437-2. Epub 2023 Sep 27.
Abnormal assembly of tau, α-synuclein, TDP-43 and amyloid-β proteins into amyloid filaments defines most human neurodegenerative diseases. Genetics provides a direct link between filament formation and the causes of disease. Developments in cryo-electron microscopy (cryo-EM) have made it possible to determine the atomic structures of amyloids from postmortem human brains. Here we review the structures of brain-derived amyloid filaments that have been determined so far and discuss their impact on research into neurodegeneration. Whereas a given protein can adopt many different filament structures, specific amyloid folds define distinct diseases. Amyloid structures thus provide a description of neuropathology at the atomic level and a basis for studying disease. Future research should focus on model systems that replicate the structures observed in disease to better understand the molecular mechanisms of disease and develop improved diagnostics and therapies.
异常聚集的 tau、α-突触核蛋白、TDP-43 和淀粉样蛋白-β 蛋白形成淀粉样纤维,定义了大多数人类神经退行性疾病。遗传学为纤维形成与疾病原因之间提供了直接联系。低温电子显微镜 (cryo-EM) 的发展使得从死后人类大脑中确定淀粉样蛋白的原子结构成为可能。在这里,我们综述了迄今为止确定的脑源性淀粉样纤维的结构,并讨论了它们对神经退行性疾病研究的影响。虽然给定的蛋白质可以采用许多不同的纤维结构,但特定的淀粉样折叠定义了不同的疾病。因此,淀粉样结构为神经病理学提供了原子水平的描述,并为研究疾病提供了基础。未来的研究应集中在复制疾病中观察到的结构的模型系统上,以更好地理解疾病的分子机制,并开发出改进的诊断和治疗方法。